Skip to Content

Amexdrug Corp AXRX

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

AXRX is trading at a 55% premium.
Price
$0.00
Fair Value
$9.46
Uncertainty
Extreme
1-Star Price
$3.36
5-Star Price
$4.35
Economic Moat
Rfhmqcx
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if AXRX is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.15 / $0.16
Market Cap
$338,819.24
Volume/Avg
6,810 / 3,472

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Amexdrug Corp is a pharmaceutical and cosmeceutical company. Along with its subsidiaries, the company engaged in the research and development, manufacturing and distribution of pharmaceutical drugs, cosmetics and distribution of prescription and over-the-counter drugs, private manufacturing and labeling, and a quality control laboratory. It has operations in two segments, Distribution; and Health and Beauty Products. The distribution segment consists of the wholesale pharmaceutical distribution and resale of brand and generic pharmaceutical products, over-the-counter drugs and non-drug products, and health and beauty products. Health and Beauty Products consist of the manufacture and distribution of primary health and beauty products.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Growth
Total Number of Employees
13

Valuation

Metric
AXRX
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
AXRX
Quick Ratio
0.67
Current Ratio
1.35
Interest Coverage
6.99
Quick Ratio
No chart available

Profitability

Metric
AXRX
Return on Assets (Normalized)
7.97%
Return on Equity (Normalized)
30.57%
Return on Invested Capital (Normalized)
13.70%
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
LyksnvnbqhLbvx$82.0 Bil
Merck KGaA ADR
MKKGY
LzpjdnpdmrKfkglpm$73.1 Bil
Haleon PLC ADR
HLN
PyvvxbjZxt$40.0 Bil
Teva Pharmaceutical Industries Ltd ADR
TEVA
KprmdvkvSxdf$19.0 Bil
Viatris Inc
VTRS
BltflgdhdZjk$13.9 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
TdqjcgnkFxm$13.6 Bil
Catalent Inc
CTLT
LlndpkytFnftscr$10.6 Bil
Perrigo Co PLC
PRGO
DshnssmCxsw$3.8 Bil
Prestige Consumer Healthcare Inc
PBH
RnmscrySqnbhg$3.5 Bil
Curaleaf Holdings Inc
CURLF
PbstfmgqKrh$3.0 Bil

Sponsor Center